$PCRX

$36.40▲ 48.75% YTD

6 SEC 13D/G filings tracked · Last updated Oct 30, 2026

Filing History

PCRX - Pacira BioSciences, Inc. - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks Simplified

$36.40▲ 48.75%Oct 30, 2026 · ThinkSabio Blog

$PCRX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PCRX Pacira BioSciences, Inc. : $36.40 Sector: Healthcare | YTD…

SEC 13D/G

PCRX - Pacira BioSciences, Inc. - SEC Filing Update (13-OCT-2026) | ThinkSabio - Stocks Simplified

$36.38▲ 48.67%Oct 13, 2026 · ThinkSabio Blog

$PCRX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #PCRX Pacira BioSciences, Inc. : $36.38 Sector: Healthcare | YTD…

News

PCRX ▲ +1.9% - Pacira BioSciences, Inc.

CP $25.72▲ +1.9%Oct 8, 2026 · ThinkSabio Blog

$PCRX will resume at 8:05 am…

News

PCRX ▲ +1.9% - Pacira BioSciences, Inc.

CP $25.72▲ +1.9%Oct 8, 2026 · ThinkSabio Blog

$PCRX Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies…

News

PCRX ▼ -0.1% - Pacira BioSciences, Inc.

CP $25.21▲ -0.1%Oct 5, 2026 · ThinkSabio Blog

$PCRX - Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom…

News

PCRX ▲ +0.2% - Pacira BioSciences, Inc.

CP $25.88▲ +0.2%Sep 9, 2026 · ThinkSabio Blog

$PCRX - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…